Outpatient continuous parenteral inotropic therapy as bridge to transplantation in children with advanced heart

Jack F Price1, Jeffrey A Towbin, William J Dreyer

  • 1Department of Pediatrics, Lillie Frank Abercrombie Section of Pediatric Cardiology, Baylor College of Medicine; Texas Children's Hospital, 6621 Fannin, MC 19345-C, Houston, TX 77030, USA.

Insights

Outpatient parenteral inotropic therapy (PIT) can reduce hospitalizations and emergency visits for children with advanced heart failure. This therapy may successfully bridge selected pediatric patients to cardiac transplantation.

Area of Science:

  • Pediatric Cardiology
  • Cardiovascular Research
  • Medical Therapy

Background:

  • Advanced heart failure in children presents significant morbidity and mortality.
  • Standard medical therapies are often ineffective for pediatric advanced chronic heart failure.

Purpose of the Study:

  • To review the institutional experience with outpatient parenteral inotropic therapy (PIT).
  • To evaluate the efficacy of PIT for advanced chronic heart failure in pediatric patients.

Main Methods:

  • Retrospective review of medical records for pediatric patients treated with outpatient PIT.
  • Analysis of patient demographics, duration of therapy, emergency department visits, hospital admissions, and ejection fraction (EF%).

Main Results:

  • Seven pediatric patients received outpatient PIT (mean age 14.6 years).
  • PIT significantly reduced emergency department visits and hospital admissions for heart failure exacerbations.
  • Mean EF% improved in patients with systolic dysfunction on PIT.
  • Six out of seven patients were successfully bridged to cardiac transplantation.

Conclusions:

  • Outpatient continuous parenteral inotropic therapy (PIT) is a viable treatment option for selected pediatric patients.
  • PIT can serve as a successful bridge to cardiac transplantation in pediatric heart failure management.
Abstract

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Heart Failure Drugs: Inotropic Agents01:26

Heart Failure Drugs: Inotropic Agents

Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
Continuous Renal Replacement Therapy01:30

Continuous Renal Replacement Therapy

Continuous Renal Replacement Therapy, also known as CRRT, is a procedural treatment for acute kidney injury (AKI) that gradually removes uremic toxins and fluids while maintaining acid-base balance and stabilizing electrolytes. It is particularly useful for hemodynamically unstable patients. Unlike intermittent hemodialysis, which is faster, CRRT provides a gentler approach over 24 hours, closely mimicking the function of natural kidneys. However, CRRT is not ideal for patients with...
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...